In Brief: LifeCell
This article was originally published in The Gray Sheet
LifeCell: Tissue graft manufacturer forecasts six-month 1996 (ends June 30) sales exceeding total sales for all of 1995. The Woodlands, Texas firm attributes the growth in sales to its "appointment of eight regional plastic surgery distributors" since March 1 and its "recent appointment of Dentsply as its worldwide distributor of AlloDerm dermal tissue graft to periodontists"...
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.